HALO
Halozyme Therapeutics Inc
Price:  
49.50 
USD
Volume:  
1,418,017.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO DCF Valuation - Growth Exit 5Y

14.4%
Upside

The Discounted Cash Flow (DCF) valuation of Halozyme Therapeutics Inc (HALO) is 56.60 USD. With the latest stock price at 49.50 USD, the upside of Halozyme Therapeutics Inc based on DCF is 14.4%.

Range Selected
WACC / Discount Rate 7.7% - 9.9% 8.8%
Long-term Growth Rate 2.0% - 4.0% 3.0%
Fair Price 39.79 - 92.78 56.60
Upside -19.6% - 87.4% 14.4%
49.50 USD
Stock Price
56.60 USD
Fair Price